PS

Pradyuman Shyamrai Mehta

Director Director DIN 02781328
DIN 02781328 First appointment Mar 1990 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 1990
Shareholding value β€’β€’β€’β€’ Premium profile

About Pradyuman Shyamrai Mehta

Data last updated:

Pradyuman Shyamrai Mehta was a Director at Cyto Pharmaceuticals Private Limited (1990–2014) and Director at R Vedic Medicines Private Limited (from 2004). The companies operate in Pharma.

DIN 02781328
Primary Designation Director
Industry Pharma
First Appointment 27 Mar 1990
Oldest Company Age 22 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cyto Pharmaceuticals Private Limited U24110MH1985PTC035226
Director27 Mar 19901985Active
R Vedic Medicines Private Limited U24230MH2004PTC149203
Director21 Oct 20042004Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
R Vedic Medicines Private Limited
Cyto Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pradyuman Shyamrai Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pradyuman Shyamrai Mehta

Pradyuman Shyamrai Mehta was first appointed on 27 Mar 1990 as Director at Cyto Pharmaceuticals Private Limited. The most recent appointment on record is 21 Oct 2004 at R Vedic Medicines Private Limited.

Pradyuman Shyamrai Mehta held 2 earlier board appointments: Cyto Pharmaceuticals Private Limited (Director, 27 Mar 1990 to 11 Jan 2014); R Vedic Medicines Private Limited (Director, from 21 Oct 2004).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available